Effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus in Chinese patients: A Meta-analysis

OBJECTIVE

To systematically evaluate the effect of conventional medical treatment plus Qigong exercise on type 2 diabetes mellitus (T2DM) in Chinese patients.

康复治疗学专业创新型人才培养的探索与实践

针对新建的康复治疗学专业本科教育,为了培养创新型康复治疗高级人才,首都医科大学康复医学院通过开设一系列科研训练课程、开展毕业设计和学术交流等教学实践活动,构建了创新型人才培养的教学体系,收到了良好的教学效果。     

微生物检验技术课程项目化教学模式的构建与实践

根据教育部在《关于全面提高高等职业教育教学质量的若干意见》文件中的精神,探索微生物检验技术的教学改革方法,构建项目化教学的模式,通过资讯—计划—决策—实施—检查—评估进行实践,有利于提高学生的综合素质,增强就业竞争力。     

丙戊酸钠慢性作用及停药后对C6神经胶质瘤细胞GAT-3及GABA-TmRNA表达的影响

目的通过研究丙戊酸钠(VPA)慢性作用及停药后对C6神经胶质瘤细胞γ-氨基丁酸转运体-3(GAT-3)和γ-氨基丁酸转氨酶(GABA-T) mRNA表达水平的影响,从星形胶质细胞的角度来探讨VPA的停药反跳机制。方法用含50 mg/L VPA的DMEM培养基将C6细胞培养2周后制成VPA慢性作用模型,采用半定量RT-PCR方法检测VPA慢性作用及停药后对C6神经胶质瘤细胞GAT-3和GABA-T mRNA表达水平的变化。结果(1)在VPA慢性作用下,相对灰度值(RV值,即GAT-3、GABA-T电泳条带与相应的β-actin灰度积分的百分比)为(39.1±0.5)%,低于正常对照组的(46±1.3)%;各停药组的RV值均低于VPA慢性作用组,其中停药24 h组的最低,为(11.7±1.6)%,停药30 min组的最高,为(38.9±0.6)%;而停药48 h组又升高到(33.5±1.1)%。(2)VPA慢性作用组[RV值为(71.31±6.91)%]与对照组[RV值为(34.77±3.26)%]相比,GABA-T mRNA表达明显上调;各停药组与VPA慢性作用组相比GABA-T mRNA的表达明显下调,其中停药12 h组[RV值为(25.36±7.68)%]降至最低。结论VPA慢性作用可使GAT-3 mRNA的表达下调,使GABA-T mRNA表达上调。VPA慢性作用后停药造成的GAT-3和GABA-T mRNA表达水平的波动可能与VPA停药反跳有关。     

Discovery of Cobimetinib as a novel A-FABP inhibitor using machine learning and molecular docking-based virtual screening

Adipocyte fatty acid-binding protein (A-FABP, also called FABP4, aP2) is an adipokine identified as a critical regulator of metabolic function due to its dual functions of fatty acid transport and pro-inflammation. Because of the high therapeutic potential of A-FABP inhibition for the treatment of metabolic diseases and related vascular complications, numerous inhibitors have been developed against A-FABP. However, none of these inhibitors have been approved for use in patients due to severe side effects. Here, we used a virtual screening (VS) strategy to identify potential inhibitors of A-FABP in the latest FDA-approved drug library (∼2600 compounds), aiming to explore the existing drugs with proven safety profiles. We firstly combined ligand-based machine learning and structure-based molecular docking to develop a screening pipeline for identifying A-FABP inhibitors. The screening of FDA-approved drugs identified four compounds (Cobimetinib, Larotrectinib, Pantoprazole, and Vildagliptin) with the highest scores, whose inhibitory effects on A-FABP were further assessed in cellular assays. Among the selected compounds, Cobimetinib significantly inhibited the activation of the JNK/c-Jun signaling pathway by A-FABP in mouse macrophages without causing obvious cytotoxicity. In summary, we present an integrated VS pipeline for A-FABP inhibitor screening, and identified Cobimetinib as a novel A-FABP inhibitor that may be repurposed for the treatment of metabolic diseases and associated vascular complications.

The integrated virtual screening pipeline was constructed to identify potential inhibitors of A-FABP in the latest FDA-approved drug library, aiming to explore the existing drugs with proven safety profiles.     

A timeline of oligodendrocyte death and proliferation following experimental subarachnoid hemorrhage

AimsWhite matter (WM) injury is a critical factor associated with worse outcomes following subarachnoid hemorrhage (SAH). However, the detailed pathological changes are not completely understood. This study investigates temporal changes in the corpus callosum (CC), including WM edema and oligodendrocyte death after SAH, and the role of lipocalin‐2 (LCN2) in those changes.MethodsSubarachnoid hemorrhage was induced in adult wild‐type or LCN2 knockout mice via endovascular perforation. Magnetic resonance imaging was performed 4 hours, 1 day, and 8 days after SAH, and T2 hyperintensity changes within the CC were quantified to represent WM edema. Immunofluorescence staining was performed to evaluate oligodendrocyte death and proliferation.ResultsSubarachnoid hemorrhage induced significant CC T2 hyperintensity at 4 hours and 1 day that diminished significantly by 8 days post‐procedure. Comparing changes between the 4 hours and 1 day, each individual mouse had an increase in CC T2 hyperintensity volume. Oligodendrocyte death was observed at 4 hours, 1 day, and 8 days after SAH induction, and there was progressive loss of mature oligodendrocytes, while immature oligodendrocytes/oligodendrocyte precursor cells (OPCs) proliferated back to baseline by Day 8 after SAH. Moreover, LCN2 knockout attenuated WM edema and oligodendrocyte death at 24 hours after SAH.ConclusionsSubarachnoid hemorrhage leads to T2 hyperintensity change within the CC, which indicates WM edema. Oligodendrocyte death was observed in the CC within 1 day of SAH, with a partial recovery by Day 8. SAH‐induced WM injury was alleviated in an LCN2 knockout mouse model.     

An antibody against Siglec-15 promotes bone formation and fracture healing by increasing TRAP+mononuclear cells and PDGF-BB secretion

INTRODUCTION Siglec-15 is a member of the sialic acid-binding immunoglobulintype lectin (Siglecs) family, a group of cell-surface receptors that potentially reg...     

开窗腰椎间盘切除再手术的远期疗效

目的探讨开窗腰椎间盘切除再手术治疗初次开窗髓核摘除术失败患者的远期疗效和影响因素。方法回顾性研究51例行第二次开窗腰椎间盘切除术的患者临床资料,随访时间120~203个月,平均随访146.8个月。按MacNab分类和JOA评分标准评价满意度和远期功能。对放射学资料完整的患者进行手术前后椎间隙高度对比研究。结果51例患者中,结果优良率70.6%,失败率15.7%,患者总体满意率78.4%。除了8例失败患者,远期随访的43例患者JOA评分平均提高(64.6±18.2)%,术后行走能力明显改善。对手术节段椎间隙高度测量发现术后椎间隙高度明显下降,但不影响远期功能结果。吸烟、是否有外伤等发病诱因、合并纤维化和初次术后症状未缓解期对远期结果有影响。心理社会因素与预后可能存在一定关系。结论开窗腰椎间盘切除再手术治疗初次开窗髓核摘除术失败患者疗效满意,但手术复杂性高,明确术前诊断和严格手术指征非常重要。JOA评分被证明为易于患者和医师实施,量化主观数据的评估法。     

Endoscopic features of esophageal high-grade intraepithelial neoplasia dominated by cytological atypia

Little is known about esophageal high-grade intraepithelial neoplasia dominated by cytological atypia (HGINc). We aimed to elucidate the endoscopic features of HGINc compared with esophageal high-grade intraepithelial neoplasia dominated by architectural atypia (HGINa). All patients pathologically diagnosed as esophageal high-grade intraepithelial neoplasia after endoscopic submucosal dissection at our center between January 2018 and December 2019 were included in this study. According to the pathological diagnosis, the patients were divided into two groups: HGINa group and HGINc group. Basic characteristics and endoscopic information were collected in detail. Data were analyzed statistically. Binary logistic regression was performed and a predictive model for HGINc was established. Then we evaluated its predictive value and built a nomogram for clinical application. A total of 175 patients were included in this study (126 with HGINa and 49 with HGINc). Among 228 lesions found in all patients, there were 148 HGINa and 80 HGINc. The independent relevant factors for HGINc were tobacco and alcohol usage, color, and gross type. To predict risk of HGINc, a three-factor model (TFM) was established with a highest area under curve (AUC) as 0.869 (95% CI, 0.852, 0.939). When the cut-off value was set as 0.3569184, the diagnostic accuracy, sensitivity, specificity, positive predictive value, and negative predictive value for HGINc was 81.14%, 88.75%, 77.03%, 67.62%, and 92.68%, respectively. HGINc differs greatly in endoscopic features from HGINa in our study. It’s important to reduce misdiagnosis that our model was established with good predictive value for clinical application.